$2.60
▼ -1.4% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
Veru (VERU) Q3 2026 Earnings Call Transcript
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Overview
52-week range
$2.05
$7.33
10% of range
Avg surprise (last 3)
+30.2%
Avg reaction (last 2)
+1.8%
50% positive
Latest IV / EM
345%
EM ±28.8% · $3 · Aug 28
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.13 | $-0.37 | +64.9% | -160.0% | -0.4% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.50 | $-0.55 | +9.1% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.05 | $-0.06 | +16.7% | — | +4.0% | earnings |
| Sun Mar 31, 2024 | Mar 2024 | $-0.07 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.08 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.42 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $0 | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-8M | $-7M | $-5M | — | $-8M | $-8M | $-10M | — |
| Net income | $-7M | $-3M | $-5M | — | $-7M | $-8M | $-9M | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24M | $28M | $33M | $16M | $15M | $20M | $27M | $25M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $27M | $33M | $37M | $19M | $16M | $21M | $28M | $35M |
| Total assets | $37M | $43M | $48M | $30M | $27M | $33M | $40M | $60M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $9M | $8M | $10M | $12M | $12M | $12M | $13M | $28M |
| Total equity | $28M | $35M | $37M | $18M | $15M | $21M | $27M | $32M |